|
|
||||||||
Viewpoint |
B Roadmap
Department of Micrbiology and Immunology, Queens University, Belfast BT9 7BL, Northern Ireland UK
SUMMARY
Signal transduction through the T cell receptor (TCR) and a costimulatory molecule, CD28, results in the stimulation of multiple signaling pathways, leading to the activation of several transcription factors including activator protein1 (AP-1), nuclear factor of activated T cells (NF-AT), and nuclear factor kappa B (NF-
B). The molecular mechanisms by which NF-
B is activated by TCRCD28 have only recently become known. New findings indicate that the adaptor molecules CARMA1 and Bcl10 are essential to the process. Additionally, a critical role for MALT1/paracaspase has been identified. MALT1, CARMA1, and Bcl10 form a tripartite protein complex, in which Bcl10 is thought to facilitate the oligomerization of MALT1 monomers. Overexpression of MALT1, as observed in a subset of lymphoma patients, leads to the potent activation of NF-
B, suggesting that MALT1 might stimulate (directly or indirectly) the kinase complex [IKK, inhibitor of NF-
B (I
B) kinase] responsible for activating cytoplasmic NF-
B for translocation into the nucleus. Moreover, the MALT1CARMA1Bcl10 complex is responsible for ubiquitination of NEMO, a step that appears to be critical for TCR-induced NF-
B activation but not for induction mediated by other stimuli such as TNF or IL-1.
This article has been cited by other articles:
![]() |
M. S. Hayden and S. Ghosh Signaling to NF-{kappa}B Genes & Dev., September 15, 2004; 18(18): 2195 - 2224. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |